APA (7th ed.) Citation

M, B., SV, S., I, A., A, M., JC, P., K, G., . . . CB, D. (2026). Banff 2024 Pancreas Transplantation Report: Diagnosis and impact of chronic active T cell-mediated allograft rejection and re-evaluation of the indeterminate category with utilization of leukocyte immunostains in biopsies with ambiguous findings. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 26(8), 1787. https://doi.org/10.1016/j.ajt.2026.04.006

Chicago Style (17th ed.) Citation

M, Büttner-Herold, et al. "Banff 2024 Pancreas Transplantation Report: Diagnosis and Impact of Chronic Active T Cell-mediated Allograft Rejection and Re-evaluation of the Indeterminate Category with Utilization of Leukocyte Immunostains in Biopsies with Ambiguous Findings." American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 26, no. 8 (2026): 1787. https://doi.org/10.1016/j.ajt.2026.04.006.

MLA (9th ed.) Citation

M, Büttner-Herold, et al. "Banff 2024 Pancreas Transplantation Report: Diagnosis and Impact of Chronic Active T Cell-mediated Allograft Rejection and Re-evaluation of the Indeterminate Category with Utilization of Leukocyte Immunostains in Biopsies with Ambiguous Findings." American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol. 26, no. 8, 2026, p. 1787, https://doi.org/10.1016/j.ajt.2026.04.006.